Tuesday, May 21, 2019

Hemp Seeds Market Tremendous Growth by 2025

By Robert Benoit
Source: foxworldmedia.com

Hemp Seeds Market
Hemp seeds. No photo credit in the source article.


Global Hemp Seeds Market 2019 is expected to demonstrate an enormous growth in the upcoming years. The analysts also have analyzed drawbacks with on-going Hemp Seeds trends and the opportunities which are devoting to the increased growth of the market. International Hemp Seeds market research report provides the perspective of this competitive landscape of worldwide markets. The report offers particulars that originated from the analysis of the focused market. Also, it targets innovative, trends, shares and cost by Hemp Seeds industry experts to maintain a consistent investigation.

The Hemp Seeds report presents an estimation of the forecast from 2019 to 2025 and market history from 2014 to 2018. The information provided in the form of earnings likely to be produced in (USD million) year to year by Hemp Seeds growth rate (CAGR). The report explains market segmentation based upon the types in addition to the leading regions featuring ‘North America, Asia-Pacific, UK, Europe, Central & South America, Middle East & Africa.’

Get Sample Copy of this Report: https://www.globalinforeports.com/request-sample/1071146

Prime Players:

Naturally Splendid, GIGO Food, Hemp Oil Canada, HempFlax, Manitoba Harvest, Canah International, Jinzhou Qiaopai Biotech, North American Hemp & Grain Co., Navitas Organics, Yishutang

Market Segment by Types, covers:

  • Hulled Hemp Seed
  • Whole Hemp Seed
  • Hemp Protein Powder
  • Hemp Seed Oil
  • Other

Market Segment by Applications can be divided into:

  • Hemp Oil
  • Hemp Seed Cakes
  • Other Application
Get More Discount: https://www.globalinforeports.com/check-discount/1071146

Key questions include:

  1. What will the growth rate and also the global Hemp Seeds industry size by 2025?
  2. What will be the elements driving the Hemp Seeds market?
  3. What will be the global Hemp Seeds market trends affecting the growth?
  4. What would be the Hemp Seeds challenges for development?
  5. Who are the profitable vendors of the market?
  6. Which would be Hemp Seeds industry opportunities and dangers faced with most vendors in the industry?
  7. What are the variables affecting the Hemp Seeds market share of APAC, the Americas, Europe, along with MEA?
  8. What will be the outcomes of this market SWOT five forces analysis?

Objectives of Information Mining

  • Providing demographics and data;
  • Providing Hemp Seeds instructions;
  • Researching global Hemp Seeds market dynamics, expansion drivers, along with business restraints;
  • Providing Scope and definition of the market;
For More Enquiry Click at: https://www.globalinforeports.com/send-an-enquiry/1071146

Customization of this Report: This Hemp Seeds report could be customized to the customer’s requirements. Please contact our sales professional (sales@globalinforeports.com), we will ensure you obtain the report which works for your needs.

Thursday, May 16, 2019

Legal marijuana is a job creation machine

By Phillip Smith
Source: alternet.org

Legal marijuana is a job creation machine
Image via Shutterstock

This article was produced by Drug Reporter, a project of the Independent Media Institute.

 

As the marijuana business emerges from the shadows and into the legal marketplace, jobs in the legal marijuana industry are coming with it—by the hundreds of thousands, with more on the way. In fact, the legal marijuana business is “currently the greatest job creation in America.”
That’s according to the marijuana information clearinghouse Leafly, which crunched the numbers in its recently released Special Report: 2019 Cannabis Jobs Count. That report finds that legal marijuana has created 211,000 full-time jobs, with more than 64,000 added last year alone, and tens of thousands more being created this year.
The marijuana workforce increased 21 percent in 2017 and jumped by another 44 percent last year, and Leafly expects at least another 20 percent growth this year. That’s a more than doubling of the industry workforce in just three years.
By way of comparison, the Bureau of Labor Statistics recently listed the industries with the fastest job growth prospects. Home health care aide positions are expected to jump 47 percent, while opening for wind turbine technicians and solar photovoltaic installers are expected to double. But that’s in the next 10 years; the marijuana industry did it in three.
Because marijuana remains federally illegal, the Bureau of Labor Statistics doesn’t count pot jobs. That left Leafly’s data team, working in conjunction with Whitney Economics, to come up with the numbers. They did so using state-reported data, industry surveys, on-the-ground reporting, Leafly’s own proprietary data, and economic formulas devised by Whitney.
The upward jobs trend is likely to continue for years to come, rolling through the individual states as they embrace medical marijuana and recreational legalization. So far, 34 states have some form of legal medical marijuana, but only 10 have achieved full-blown legalization, so the medium-term job creation potential is substantial.
We can see this playing out in the states that have legalized marijuana. Early legalizers Colorado and Washington saw double-digit jobs growth last year—17 percent and 26 percent, respectively—but these numbers actually represent a plateauing as their legal markets mature. Triple-digit job growth figures are common as states come online. In Florida, when medical marijuana dispensaries opened up last year, the state added more than 9,000 pot jobs, a stunning increase of more than 700 percent.
The Sunshine State wasn’t alone in seeing huge job increases last year. Nevada added more than 7,500 jobs, Pennsylvania went from 90 pot jobs to nearly 4,000, and New York nearly tripled the number of full-time positions. By year’s end, more than 5,000 New Yorkers worked in the industry.
This year, Leafly predicts the biggest harvest of new jobs in the industry will come in California, where hiring was flat last year because of disruptions caused by the shift from the unlicensed medical system to tightly regulated adult-use legalization. The Golden State should see 10,000 new pot jobs, bringing total employment to around 60,000.
Massachusetts, where the adult-use market is just getting started, is set to add some 9,500 positions, while Florida’s roll-out of medical marijuana should see pot jobs increase by 5,000 this year, bringing the total for the state to 15,000. In Oklahoma, there were no legal pot jobs in 2018, but with the November 2018 victory of a medical marijuana initiative, there are more than 2,100 jobs now, which should more than double to 4,400 by year’s end. Similarly, Arkansas, where the first dispensary is set to open any day now, the number of industry positions is expected to go from 135 now to nearly a thousand before the year is up.
Now, just imagine what happens when states such as Connecticut, Illinois, New Jersey, and New York manage to actually get legalization bills through the legislature. The jobs will follow in a wave that will eventually spread across the county until it submerges even the last stubborn prohibitionist holdouts in places like South Carolina and South Dakota. The pot jobs boom isn’t ending; it’s just getting underway.

Wednesday, May 8, 2019

What Is CBN and What Are the Benefits of This Cannabinoid?

By Bailey Rahn
Source: leafly.com

Image result for what is cbn

Do you remember the first time you heard about cannabidiol, or CBD? Remember how the national opinion of cannabis changed drastically once we gained knowledge of its non-intoxicating compounds? And who could forget how this discovery impacted the lives of children suffering from seizures and patients with chronic pain, anxiety, and inflammation?

What you may not know is there are many other medicinal compounds like CBD unique to cannabis that we’re becoming acquainted with. Allow us to introduce you to yet another of these therapeutic offerings, CBN.

What Are CBN’s Effects and Benefits?

Its name may bear striking resemblance to CBD, but cannabinol, or CBN, offers a unique profile of effects and benefits that have researchers clamoring for more scientific investigation. So far, CBN’s studied benefits include:
CBN’s most pronounced, characterizing attribute is its sedative effect, and according to our friends at Steep Hill Labs, 5mg of CBN is as effective as 10mg dose of diazepam, a mild pharmaceutical sedative. For those of you who rely on cannabis to resolve a night of tossing and turning, a little CBN might do you some good.

Unlike THC, CBN induces little to no intoxicating effects. This is great news for patients needing to medicate with a clear head, but you should note that most flowers contain only trace amounts of CBN. Where THC contents can hit a high watermark of over 30%, CBN rarely exceeds 1% in dried flower. It’s a good thing a little bit goes a long way. Alternatively, seek out a product that has concentrated CBN for you.

Where Can I Find CBN?

As THC oxidizes (i.e. exposure to oxygen over time), it converts to CBN. This is why aged, poorly stored cannabis is likely to have higher levels of CBN than fresh flower in an air-tight container.
CBN has a lot to offer patients and sufferers of sleeplessness, but before dooming yourself to a life of shwag and parched buds of yesteryear, know that CBN-rich products are already on the way. Oils, edibles, tinctures, capsules, and patches with pronounced CBN profiles are rare, but their proliferation will undoubtedly grow with the changing attitudes toward cannabis. Until then, look for lab-tested flowers and concentrates exhibiting high CBN levels. (Or just keep soldiering through that 2-year-old snicklefritz. We won’t judge.)

Monday, May 6, 2019

Hemp Is The New Oak: America’s First Hemp “Wood” Factory Is Being Built

By Richard Parks
Source: inspiretochange.org

Since the cultivation of hemp (cannabis, marijuana, pot) is now completely legal in all the 50 states in the U.S, there’s no reason for entrepreneurs not to explore the different possible uses of the hemp and its components. Hemp has both legalized medical and recreational uses, but these functions are mostly derived from the plant’s leaves.

An ingenious innovation now uses the plant’s stalk to produce wood that is said to be 20 times harder than oak.

Before the legalization of hemp in the United States, Greg Wilson was already a pioneer in the bamboo flooring industry. He founded SmartOak®, a company that engineers wood products from barely useful logs that would have been converted to chips for fuel. He is all into the wood, and as an avid entrepreneur, he’s constantly on the lookout for more marketable products in the wood business. He’s the brain behind Fibonacci LLC, the startup company that patented HempWood. The 6 million-dollar factory is under contraction in Kentucky (headquarters) where 40,000 acres of hemp is already being cultivated.
 
A review published on Science Direct states that 14 oak tree species are critically endangered due to the high demand for oak for furniture-making [1]. An oak tree takes at least 6 decades to reach full maturity, while a thicket of hemp plants mature fully in 6 months, possibly growing to a density of 150 plants per square meter [2]. Hemp plants, therefore, grow 100 times faster than oak, and despite the fact that upon finishing, the two wood varieties possess similar outward appearances, HempWood is 20 times stronger.
Hemp fibers, much like glass fiber, have a high degree of rigidity and tensile strength. Also, the use of HempWood would be beneficial to the reforestation process since it will reduce the cutting of trees for furniture and construction needs.
 
The finished HempWood is made by gluing together fiber strands from hemp pulp using a soy-based glue. Since hemp fiber strands are appreciably long, the manufacturing process will be based on the Chinese technology of cutting bamboo strips into long, ultra-tiny strands before interweaving them together with glue. This is an industrial process used to manufacture wood products that are more appealing to the eyes than grain-based wood.
 
When HempWood is commercialized, it will be used in the manufacture of shelves, cupboards, tables, boards, floors, skateboards and lots more. According to Greg Wilson, the product will be far cheaper than oak products.

The State of Kentucky is solidly behind Wilson, whereby the Kentucky Economic Development Finance Authority issued him $300,000 in tax incentives. There’s also a possible award of a percentage of the investment funds if the company’s performance value is high.
 
So, hemp isn’t just for getting high or having fun. This product will not only boost reforestation efforts, but it will also open wide doors of opportunity in the wood and construction industries. It will also take solid chips out of the labor market through the creation of jobs as the company’s wings spread. Most likely, in a few years, other entrepreneurs will buy into the idea, creating more companies, and hence, more jobs.

 A win-win situation.
References:
  1. Conservation and fruit biology of Sichou oak (Quer cus sichourensis, Fagaceae) – A critically endangered species in China. Xia et al. Science Direct. October 2016.
  1. Hemp Fiber / Hemp Fiber / Hemp Wood, Chopped. Reade.
  1. Hemp is now legal. That’s huge for the CBD industry. Chavie Lieber. Vox. December 28, 2018.
  2. Medical Marijuana FAQ. WebMD.
  3. The recreational use of cannabis. Hash Marijuana and Hemp Museum.
  4. Fibonacci LLC. Official website.
  5. HempWood. Official website.
  6. Made-in-China. Official website. Retrieved from
 

Florida Legislature Approves Hemp Legalization

Source: ganjapreneur.com

See the source image

Florida lawmakers have approved a measure to legalize industrial hemp cultivation in the state, moving it to Gov. Ron DeSantis for his signature, the Associated Press reports.

The bipartisan bill passed the Senate unanimously and Republican State Sen. Rob Bradley called its passage an “exciting and historic day for the state’s struggling agriculture community.”
“There has been a lot of struggles in our agriculture community over the last several years, from citrus greening to the hurricanes, and they’ve had a devastating effect on many of our farmers. This is a lifeline. This is an emerging agricultural crop that can make all the difference.” – Bradley to the Associated Press
Agricultural Commissioner Nikki Fried was present on the Senate floor for the vote. She said the state has the “right environment” and “right conditions” for hemp production.

“We are known for citrus, so we’re definitely going to continue encouraging our citrus industry,” Fried told the AP. “If they need to utilize some of their property for hemp production, this gives them another option as we’re figuring out and finding a solution to citrus greening.”

Florida is the latest state to legalize hemp following the crop’s federal legalization last year via the Farm Bill. Last month, lawmakers in Hawaii, Iowa, and Oklahoma each sent hemp legalization measure to their respective governors, while the Texas House passed its hemp legislation to the Senate. Under the Farm Bill, state programs must be approved by the U.S. Department of Agriculture before they can be rolled out.

DeSantis’ office has not signaled whether he will sign the bill.

Sunday, May 5, 2019

China Cashes in on the Cannabis Boom

By Steven Lee Myers
Source: nytimes.com


Cannabis growing in Yunnan Province in China in 2004. Yunnan is now licensing companies to cultivate the plant to produce cannabidiol.CreditCreditLeisa Tyler/LightRocket, via Getty Images


SHANCHONG, China — China has made your iPhone, your Nikes and, chances are, the lights on your Christmas tree. Now, it wants to grow your cannabis.

Two of China’s 34 regions are quietly leading a boom in cultivating cannabis to produce cannabidiol, or CBD, the nonintoxicating compound that has become a consumer health and beauty craze in the United States and beyond.

They are doing so even though cannabidiol has not been authorized for consumption in China, a country with some of the strictest drug-enforcement policies in the world.

“It has huge potential,” said Tan Xin, the chairman of Hanma Investment Group, which in 2017 became the first company to receive permission to extract cannabidiol here in southern China. The chemical is marketed abroad — in oils, sprays and balms as treatment for insomnia, acne and even diseases like diabetes and multiple sclerosis. (The science, so far, is not conclusive.)

The movement to legalize the mind-altering kind of cannabis has virtually no chance of emerging in China. But the easing of the plant’s stigma in North America has generated global demand for medicinal products — especially for cannabidiol — that companies in China are rushing to fill.

Hanma’s subsidiary in Shanchong, a village in a remote valley west of Kunming, the capital of Yunnan Province, cultivates more than 1,600 acres of hemp, the variety of cannabis that is also used in rope, paper and fabrics. From the crop, it extracts cannabidiol in oil and crystal form at a gleaming factory it opened two years ago, in a restricted zone next to a weapons manufacturer.

“It is ery good for people’s health,” Tian Wei, general manager of the subsidiary, Hempsoul, said during an interview at the factory, which was punctuated by test gunfire from the manufacturer next door.

“China may have become aware of this aspect a little bit late, but there will definitely be opportunities in the future,” Mr. Tian said.

China has, in fact, cultivated cannabis for thousands of years — for textiles, for hemp seeds and oil and even, according to some, for traditional medicine.

The Divine Farmer’s Classic of Materia Medica, a text from the first or second century, attributed curative powers to cannabis, its seeds and its leaves for a variety of ailments.


 

The company Hempsoul extracts cannabidiol from the hemp it grows on more than 1,600 acres in Yunnan Province. “It is very good for people’s health,” said the general manager, Tian Wei.CreditSteven Lee Myers/The New York Times


“Prolonged consumption frees the spirit light and lightens the body,” it said, according to a translation cited in an article in the journal Frontiers in Pharmacology.

The People’s Republic of China, after its founding in 1949, took a hard line on illegal drugs, and cultivating and using marijuana are strictly forbidden to this day, with traffickers facing the death penalty in extreme cases.

After signing the United Nations Convention on Psychotropic Substances in 1985, China went even further. It banned all cultivation of hemp — which had long been grown in Yunnan, a mountainous province that borders Myanmar, Laos and Vietnam and is among China’s poorest. Farmers produced hemp to make rope and textiles and China had banned it even though it has only trace amounts of tetrahydrocannabinol, or THC, the mind-altering compound found in marijuana.

At a news conference in Beijing last month, Liu Yuejin, deputy director of the National Narcotics Control Commission, said the momentum toward legalization in other countries meant the Chinese authorities would ”more strictly strengthen the supervision of industrial cannabis.”

The Hempsoul factory has dozens of closed-circuit cameras that stream videos directly to the provincial public security bureau.

China relented on industrial hemp only in 2010, allowing Yunnan to resume production. Hemp then was used principally for textiles, including the uniforms of the People’s Liberation Army, but soon the products expanded.

The growing industry has brought much-needed investment to Yunnan. The mild, springlike climate is exemplary for growing cannabis, and a farmer can earn the equivalent of $300 an acre for it, more than for flax or rapeseed, Mr. Tian of Hempsoul said.

Hempsoul is one of four companies in Yunnan that have received licenses to process hemp for cannabidiol, putting more than 36,000 acres under cultivation. Now others are joining the rush.

In February, the province granted a license to three subsidiaries of Conba Group, a pharmaceutical company based in Zhejiang Province. A company based in the city of Qingdao, Huaren Pharmaceutical, said recently it was applying for permission to grow hemp in greenhouses, which already line the landscape around Kunming.

Other regions have taken notice, too. In 2017, Heilongjiang, a province along China’s northeastern border with Russia, joined Yunnan in allowing cannabis cultivation. Jilin, the province next door, said this year that it would also move to do so.

The flurry of announcements sent the companies’ stocks soaring on Chinese exchanges, prompting regulators to step in to restrict trading.


 

China has cultivated cannabis for thousands of years. Yang Ming, a leading expert on hemp, said the plant’s seeds were traditionally formed into a ball and used to treat constipation.CreditSteven Lee Myers/The New York Times


While the health benefits of cannabidiol remain uncertain, the United States Food and Drug Administration last year approved the first use of it as a drug to treat two rare and severe forms of epilepsy. Other potential uses are being studied.

China permits the sale of hemp seeds and hemp oil and the use of CBD in cosmetics, but it has not yet approved cannabidiol for use in food and medicines. So, for now, the bulk of Hempsoul’s product — roughly two tons a year — is bound for markets overseas. Mr. Tian said he believed it was only a matter of time before China, too, approved the compound for ingestion.

Hanma’s ambitions are global. It has acquired an extraction plant in Las Vegas, which is expected to begin production soon, and it plans one in Canada. Mr. Tan, the chairman, said he hoped that China, with the world’s largest market, would follow the lead of the United States, which he called “the best-educated” market for the benefits of cannabis.

“It’s a new application, but one that carries forward our tradition,” he said, citing the ancient texts describing its medicinal purposes.

Yang Ming, a scientist with the Yunnan Academy of Agricultural Science who is one of China’s leading experts on hemp, said the plant’s seeds were traditionally formed into a ball and used to treat constipation, but the psychotropic qualities of cannabis were not broadly known by farmers or other residents.

As China gradually opened up following the Cultural Revolution, however, foreign visitors to Yunnan in the late 1980s and early 1990s discovered an abundance of cannabis growing wild. That, in part, turned the region into a destination for backpackers and adventurers seeking a certain kind of experience.

“They would go to the villagers’ cannabis fields, pick the buds and bring them back to the hotel to dry and smoke,” Dr. Yang said. “Some of them became deranged and ran around naked after smoking it.”

That’s when the authorities intervened. Dr. Yang, originally from Yunnan, was a recent graduate of the agricultural university in Beijing at the time. He was assigned to study cannabis, and he has been doing so ever since. His avatar on social media is a cannabis leaf.

The academy has been breeding its own varieties of hemp — each of which requires approval from the police — to ensure the plant contains less than 0.3 percent of THC, the international standard for cannabis. There are nine varieties now, and Dr. Yang’s team continues to research more.

One of the varieties, Yunnan Hemp No. 7, allows the extraction of greater amounts of cannabidiol. While the compound’s use in commercial products remains in its infancy, Dr. Yang has watched the stigma of its association with marijuana begin to evaporate.

“Other countries,” he said, with pride of parenthood, “really like our CBD.”

Claire Fu contributed research.


Tuesday, April 23, 2019

Federal Marijuana Legalization Is Close, Suggests Canopy-Acreage Deal

By Mike Adams
Source: forbes.com

Getty

Sometimes it is necessary to read between the lines. So, when the largest cannabis company in the world enters into a multi-billion dollar deal with a well-known American cannabis firm -- one that is set to take effect only after the federal government repeals marijuana prohibition -- it is hard not to consider the possibility that someone knows something and that maybe, just maybe we are closer than we think to living in a time when marijuana is taxed and regulated nationwide in a manner similar to alcohol and tobacco.
It was just last week that Canopy Growth signed a $3.4 billion agreement to acquire the medical marijuana firm Acreage Holdings. You might remember Acreage for its failed attempt at getting a cannabis advertisement approved as part of the sporting circus known as Super Bowl LIII. The basis of the agreement is that as soon as the U.S. government finally musters up the guts to end marijuana prohibition once and for all, Canopy will -- snap, bang, boom, just like that -- assume the Acreage properties and hit the ground running as the most powerful cannabis seller in the United States.
Although the deal is still contingent on several details – like stockholder agreement and regulatory approval by both the U.S. and Canada – neither company seems concerned that their mingling will be contested.
“Our right to acquire Acreage secures our entrance strategy into the United States as soon as a federally-permissible pathway exists,” Bruce Linton, co-CEO for Canopy, said in a press release. “By combining Acreage’s management team, licenses and assets with Canopy Growth’s intellectual property and brands, there will be tremendous value creation for both companies’ shareholders.”
There are a few rather interesting aspects of this arrangement. The first of which is the fact that Constellation Brands, maker of the beers Corona and Modelo, owns 37 percent equity stake in Canopy, and has an opportunity to take controlling interest in the next few years. So it is conceivable that, regardless of how much the cannabis industry fights to become its own entity with its own set of unique rules, one of the largest brewers in the world is also poised to become the most significant cannabis producer in the United States. Considering that Constellation is already working with Canopy to devise THC-beverages for the Canadian market, all of which is being done in experimental preparation for when the United States goes fully legal, it is difficult to see the point where they might opt out. Indeed, Big Alcohol is becoming Big Cannabis.
 
And then there is the John Boehner factor. The former House Speaker sits on the board of Acreage Holdings and is also the honorary chairman for an enthusiastic gang of pot lobbyists known as the National Cannabis Roundtable (NCR). This group is reportedly heavily funded by the cannabis trade, with foot soldiers in DC right now, persuading federal lawmakers to show support for issues ranging from medical marijuana research to getting the federal government to fall in line with the marijuana standards of today. One piece of legislation that this group is particularly motivated to get on the books is the STATES Act, which would allow states to legalize marijuana any way they see fit without the possibility of federal interference. It’s the one cannabis-related bill that President Trump has said he would “probably” sign if Congress can come to terms.
Boehner has alluded in the past that he has a grip on how the votes will shake out in Congress when the time comes to get serious about ending prohibition.
“I’ve been having more and more meetings with my friends and colleagues on the Hill about this — some of the most conservative politicians around and their views are evolving on cannabis, too, just like the American people,” he said last year during a speech at the American Cannabis Summit.
Boehner has also indicated that full-blown legalization is already a hot topic of discussion and on its last leg. “I have a strong suspicion we won’t be waiting five years to see the federal government legalize cannabis,” he said. “I’ve got to choose my words carefully. What I’m hearing behind closed doors is pretty sensitive.”
But the latest deal between Canopy and Acreage suggests that a timeline for nationwide marijuana legalization may already be established. After all, why would a company shell out a $300 million deposit on an acquisition that may never come to pass? It is even a stretch to suggest that a company, even one as seemingly well off as Canopy, would toss such a hefty chunk of investment capital into American weed without some kind of assurance that the laws were on the verge of change.
I guess what I’m trying to say is: if you’re reading between the lines, this contract between Canopy and Acreage was signed, presumably, because Boehner has the 4-1-1 on the Congressional cannabis chatter and has convinced all of the parties involved that U.S. pot prohibition is coming down – and like, sooner than later.
But will it be this year or next?